OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022
Loreto Núñez, Muriel Ramírez-Santana, Paola Rubilar, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 201-201
Open Access | Times Cited: 11
Loreto Núñez, Muriel Ramírez-Santana, Paola Rubilar, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 201-201
Open Access | Times Cited: 11
Showing 11 citing articles:
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023
Jira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Jira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
The Second Round of a Population‐Based Seroprevalence Study of Anti–SARS‐CoV‐2 Antibodies and COVID‐19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina
Jela Aćimović, Biljana Mijović, Srdjan Mašić, et al.
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 1
Open Access
Jela Aćimović, Biljana Mijović, Srdjan Mašić, et al.
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 1
Open Access
SARS-CoV-2 seropositivity amongst healthcare workers in South Africa during the Omicron wave: natural infection versus vaccination
Daniel Hoffmann, Pieter Meyer, Catherine Worsley, et al.
Journal of Clinical Pathology (2025), pp. jcp-209722
Closed Access
Daniel Hoffmann, Pieter Meyer, Catherine Worsley, et al.
Journal of Clinical Pathology (2025), pp. jcp-209722
Closed Access
Population-based seroprevalence survey: post-pandemic COVID-19 vaccination, related factors, and geographic distribution of vaccine acceptability in Chile
Loreto Núñez, Paola Rubilar, Mauricio Apablaza, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Loreto Núñez, Paola Rubilar, Mauricio Apablaza, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Dynamics of multisystem inflammatory syndrome in children associated to COVID-19 in Chile: Epidemiologic trends during pandemic, before and after children vaccination
Rodolfo Villena, Giannina Izquierdo, Jochen Wilhelm, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126015-126015
Closed Access | Times Cited: 2
Rodolfo Villena, Giannina Izquierdo, Jochen Wilhelm, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126015-126015
Closed Access | Times Cited: 2
SARS-CoV-2 infectivity and antigenic evasion: spotlight on isolated Omicron sub-lineages
Aldo Barrera, Constanza Martínez-Valdebenito, Jenniffer Angulo, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Aldo Barrera, Constanza Martínez-Valdebenito, Jenniffer Angulo, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Overcoming Health Inequities: Spatial Analysis of Seroprevalence and Vaccination Against COVID-19 in Chile
Muriel Ramírez-Santana, Juan Correa, Loreto Núñez Franz, et al.
Health Equity (2024) Vol. 8, Iss. 1, pp. 558-567
Open Access | Times Cited: 1
Muriel Ramírez-Santana, Juan Correa, Loreto Núñez Franz, et al.
Health Equity (2024) Vol. 8, Iss. 1, pp. 558-567
Open Access | Times Cited: 1
Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study
Juan Hormazábal, Loreto Núñez, Paola Rubilar, et al.
Vaccine X (2023) Vol. 15, pp. 100372-100372
Open Access | Times Cited: 2
Juan Hormazábal, Loreto Núñez, Paola Rubilar, et al.
Vaccine X (2023) Vol. 15, pp. 100372-100372
Open Access | Times Cited: 2
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: A cross-sectional survey from October 2022 to January 2023
Jira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Jira Chansaenroj, Nungruthai Suntronwong, Sitthichai Kanokudom, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
